Glaxo reports Lucozade sales pressure
Drug maker GlaxoSmithKline today said sales of its Lucozade drink slumped 12% as it announced lower quarterly profits amid slumping US performance.
The pharmaceuticals giant said its sports and energy drinks suffered as UK consumers shied away from impulse buys.